SECTIONS

Methicillin-resistant Staphylococcus (MRSA)

Vancomycin-resistant Enterococci (VRE)

Our Rates

MRSA Rate

The method of calculation of the MRSA bacteraemia infection rate for the reporting period (on a quarterly basis) is:

    Number of nosocomial patients with laboratory identification of MRSA bacteraemia X 1000    
Total # of patient days (quarterly)

Where the numerator is the total number of newly identified cases for MRSA bacteraemia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.

VRE Rate

The method of calculation of the VRE bacteraemia infection rate for the reporting period (on a quarterly basis) is:

    Number of nosocomial patients with laboratory identification of VRE bacteraemia X 1000    
Total # of patient days (quarterly)

Where the numerator is the total number of newly identified cases for VRE bacteraemia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.

 

	Q4 2019/2020	Q1 2020/2021	Q2 2020/2021	Q3 2020/2021	Q4 2020/2021
Number of new MRSA cases	1	2	10	10	1
MRSA Rate	0.07	0.40	0.67	0.69	0.07
Number of new VRE cases	0	0	0	0	0
VRE Rate	0.00	0.00	0.00	0.00	0.00

 

	Q1 2021/2022	Q2 2021/2022	Q3 2021/2022	Q4 2021/2022
Number of new MRSA cases	0	0	1	0
MRSA Rate	0.00	0.00	0.06	0.00
Number of new VRE cases	0	0	0	0
VRE Rate	0.00	0.00	0.00	0.00

 

	Q1 2022/2023	Q2 2022/2023	Q3 2022/2023	Q4 2022/2023
Number of new MRSA cases	0	0	0
MRSA Rate	0.00	0.00	0.00
Number of new VRE cases	0	0	0
VRE Rate	0.00	0.00	0.00